No coin nor oath required. For personal study only.
AarhusKarlshamn (AAK), Sweden, has finalized its negotiation of a 50:50 joint venture with Enzymotec; an Israeli development company of biofunctional and nutraceutical ingredients which focusses on advanced lipids.
The resulting new company "Advanced Lipids" is said to extend AAK's business in the infant food business sector on a global basis. It is based on Enzymotec's research and AAK's international strength within development, production and marketing of speciality fats, say the companies. The corporation is to generate profit from 2008.
๐ SIMILAR VOLUMES
A long-term supply agreement was signed between Cargill and the Ghana Cocoa Board in June 2006 paving the way for this plant to be built. It will produce cocoa liquor, butter and powder, processing 65,000 tonnes initially, with the potential to expand to 120,000 tonnes says Cargill. The plant is exp
Patients treated with NKO had significantly reduced risk for cardiovascular events over the next 10 years, by 52%. \* Patients treated with NKO had a significantly higher chance to prevent cardiovascular events (-52.3%) over the next
Cargill to form joint venture with major Spanish